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Background: Parents caring for a child with Cystic Fibrosis (CF) are at high risk for psychological distress and have
limited access to psychological care. Therefore, a web-based psychological support program for severely distressed
parents of children with CF (WEP-CARE) was developed and evaluated for its feasibility and efficacy.
Methods: A clinical expert panel developed WEP-CARE based on principles of cognitive-behavioral therapy. This web-based
writing therapy comprises nine sessions, tailored for the specific needs of caregivers. The pilot study was conducted as a
single-group intervention with pre-post-follow-up design. Out of 31 participants, 23 parents completed the intervention
(21 female; mean age 37 years; SD = 6.2 years, range 25 – 48 years). Psychological symptoms and quality of life were
assessed online by self-report measures at pre- and post-treatment and were followed up three months later.
Results: On average, the caregivers’ symptoms of anxiety decreased statistically significant and clinical relevant about
five points from an elevated (M = 11.4; SD =2.6) to a normal level (M = 6.7; SD = 2.6; p < .001) between pre and post
treatment. Fear of disease progression (p < .001) and symptoms of depression (p = .02) significantly decreased as well.
Quality of life significantly improved (p = .01). The effects were maintained at the 3-months follow-up assessment.
Conclusions: WEP-CARE is feasible and promising regarding its efficacy to improve parental mental health and quality
of life.
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Cystic Fibrosis (CF) is the most common inherited
chronic and life limiting condition among Caucasians [1]
with estimated between 70,000 and 100,000 patients
worldwide [2]. Due to advances in diagnoses and clinical
care, the great majority of the affected children nowadays
survive into adulthood [3,4]. Nevertheless, CF as progres-
sive and multi-organ disease impacts the functioning of
the lungs and the pancreas, and requires an extensive and
time-consuming therapy. Maintaining the daily disease-
management is a challenge and coping with disease pro-
gression puts a high burden on the patients themselves
and especially on their caregivers. Although the majority
of caregivers cope well with their child's disease, parents* Correspondence: astrid.fidika@uniklinik-ulm.de
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unless otherwise stated.of children with chronic conditions are known to be at
high risk for developing psychosocial problems or disor-
ders [5] and for impairments in their quality of life [6].
There is also substantial evidence of impaired life satisfac-
tion and of a high prevalence of symptoms of anxiety and
depression among caregivers of children with CF [7-9].
Within the context of chronic conditions parents are con-
fronted with real threats, which might be overwhelming
and may lead to difficulties to cope with everyday life and
problems in the management of their child’s treatment
routines. Fear of disease progression is known to be a rele-
vant cause of distress in patients with chronic somatic
conditions or their partners [10]. It is likely an issue for
parental caregivers as well. In the long term the caregivers'
illness-related distress may impair adherence to treat-
ment [8] and thus result in worse disease outcomes in
the child [7].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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behavioral and problem solving interventions for parents
of children with chronic conditions [11] studies investigat-
ing interventions for parents of children with CF are scarce
[12]. Although the European consensus about standards of
care in patients with cystic fibrosis claims integrated
psychosocial care in CF centers [13,14], just a fractional
amount of parents with clinically relevant symptoms of
anxiety and/or depression received some kind of mental
health care in a German study [15], indicating limited
utilization and access to integrated psychosocial care.
Du to unresolved reimbursement problems only a minor-
ity of German CF centers are able to directly offer psycho-
logical interventions to caregivers, and referrals to mental
health services are impeded by long waiting lists. Barriers
to caregivers' treatment comprise long distances to the CF
center, restricted time capacities to care for themselves
due to the demanding management of their child’s disease,
or less awareness of the own well-being compared to the
well-being of the child.
A wide range of studies on several mental disorders
indicate that web-based interventions are efficacious
and effective opportunities to overcome the mentioned
barriers [16,17]. Research on web-based interventions in
the context of pediatric chronic conditions is increasing.
Studies on asthma or diabetes focused on optimization
of disease management or on the patients themselves
[18-20]. Only few studies addressed caregivers. Some of
those studies examined online peer support, for ex-
ample for parents of children with asthma and allergies
[21], or educational programs to support parents fol-
lowing pediatric injury [22], or web-based problem solving
intervention for families with children with traumatic
brain injury [23]. However, no study so far investigated a
web-based psychotherapeutic intervention solely for care-
givers to address parental distress, related to the chronic
condition of their child.
Due to the relevance of accessible psychotherapeutic
support for caregivers of children with chronic conditions,
the aim of the current study was to develop a web-based
intervention for distressed caregivers of minors with CF
which enables them to better cope with fears and demands
of their child’s illness and evaluate it within a pilot study.
We focused on the following research questions: First, we
examined whether a web-based cognitive-behavioral writ-
ing therapy is feasible. Secondly, we investigated whether
the intervention is efficacious to reduce symptoms of
anxiety from pre-treatment to post-treatment (primary
outcome). Furthermore, we expected that fear of dis-
ease progression and symptoms of depression would also
decrease, parental quality of life (PQoL), as well as effect-
ive parental coping would increase. At least, we hypothe-
sized that the benefit of treatment would persist until
three months after completion of the intervention.Materials and methods
Trial design
This study was conducted as a single-group intervention
study. Primary outcome were symptoms of anxiety. The
study protocol was approved by the Institutional Review
Board (IRB) of the University of Ulm. All participants
provided their written informed consent.
Participants and procedure
The study was conducted through a secure internet plat-
form (https://muko-wep.ulmer-onlineklinik.de/). Partici-
pants were recruited over a period of six months (June
2012 to December 2012) by various ways of distribution
of information. In collaborating German speaking CF
centres, flyers were distributed during routine visits. In-
formation about the study was published in a member
magazine, on the Facebook page and send via mailing
lists of the German Cystic Fibrosis Association.
Eligible were caregivers of a child with CF (0–17 years)
with clinically relevant symptoms of anxiety (≥8) on the
anxiety subscale of the Hospital Anxiety and Depression
Scale [24], being fluent in written German language, and
having access to the internet during the intervention.
Parents needed to be free of psychotic symptoms and
suicidality. Parents who reported one of those symptoms
were immediately contacted by the PI of the study to
clarify symptoms and indication for psychiatric care. Par-
ents who reported starting or changing of psychotropic
medication about six weeks prior or during the interven-
tion period, as well starting a competitive psychotherapy
were excluded from the analysis.
Interested parental caregivers could register on the
study website and then completed questionnaires. Par-
ents turning out to be eligible for the study were asked
to provide their written informed consent via mail. Parents
who did not qualify for the study received a message
recommending other opportunities to receive support.
Intervention
The web-based psychological support program for care-
givers (WEP-CARE) was developed by a clinical expert
panel, based on previous studies [9,15,25,26] and a re-
view of the literature on families coping with the CF of a
child. The panel comprised clinicians with expertise in
psychological counselling of patients with CF and their
caregivers, and a clinician-researcher with expertise in
internet-therapy. It is designed as web-based cognitive-
behavioral writing therapy with three treatment compo-
nents addressing the following disease-related aspects
considered as relevant for caregivers of a child with CF:
1) exposure to thoughts associated with anxiety and en-
hance cognitive coping with the disease, especially with
fears of disease progression, 2) sharing responsibility for
the treatment of the child, and 3) increasing self-care.
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pleted within a timely standard of dealing approximately
45 minutes with the topic. The caregivers provided their
written responses to nine standardized writing assignments
and received individualized feedback to each delivery by
their therapist within 48 hours. Thus, the communication
of participants and interventionists was asynchronous all
the time. Details of the treatment components and the
corresponding writing assignments are summarized in
Table 1.
The intervention program was provided by two trained
and supervised psychotherapists with expertise in psy-
chosocial care for patients with CF and their families.
Usability testing of WEP-CARE was conducted with
three caregivers. The treatment manual is available from
the authors on request.Outcomes
Demographic and medical information were collected at
baseline. All other questionnaires were administered at
baseline, after completion of the last treatment session,
and three months after completion of the program.Demographic and medical information
The following socio-demographic and medical data were
collected by a self-constructed questionnaire: caregivers’
age, gender, native language, education level, employment
status, living situation, experiences with the internet, and
recently received psychological care, as well as the child’s
age, gender, and the following health-related variables:
pulmonary function (FEV1%), CF-related diabetes, haemop-
tysis, pneumothorax, chronic colonization with germs, liver
problems, and being on a waiting list for a transplantation.Table 1 Content of the intervention program
Treatment component Writing assignment and its aims an
Preparation Scheduling and providing potential da
#1 – Reflection of current appraisal of
condition upon their life using a meta
Coping with anxiety and fear of
disease progression
#2 – Selection of an anxiety-provoking
and their associated thoughts and fee
#3 – Restructure own fear-provoking t
help their friend to develop a new persp
#4 – Intensification via a second letter
adaptive and accurate perspective of t
#5 – Development of a strategy how t
Sharing responsibility for treatment #6 – Reflection on the allocation of trea
#7 – Report of status of implementation
barriers and development of strategies to
Providing self-care #8 – Learn to appraise positive things in
positive experiences each day and plan
Summary and integration #9 – Reflection and integration of the thSymptoms of anxiety
Symptoms of anxiety were assessed with the anxiety sub-
scale of the German version of the Hospital Anxiety and
Depression Scale (HADS) [24]. The HADS is an easy-to-
administer and brief screening measure used for assessing
symptoms of anxiety and depression on two subscales
(seven items each scale). On a four-point rating scale,
ranging from zero to three, patients indicate the extent
of every symptom with regard to the last seven days.
For clinical discrimination of symptoms the following
established cut-offs for the raw scores of each scale
were used: normal (0–7 points), borderline (8–10 points),
and clinical level (>11 points). The HADS is valid for
using it in clinical as well as in community settings and
has good psychometric properties [24].
Symptoms of depression
The short form of the German version of the Center of
Epidemiologic Studies Depression Scale (CES-D) [27] was
administered to assess following major components of
depression: depressive mood, feelings of guilt and worth-
lessness, loss of appetite, and sleep disturbances. It is a
15-item self-report screening instrument for symptoms
of depression. The On a 4-point scale (0 to 3) the fre-
quency of symptoms are rated with regard to the last
week. A total score is calculated (range 0 to 45). Psy-
chometric properties are reported as excellent [27].
Cronbach’s alpha for the CES-D was appropriate for the
use of the instrument in the study sample (α = .82).
Fear of disease progression
The Fear of Progression questionnaire for caregivers of
youths with CF (FoP-Q-C) consists of 16 items, which
were derived from existing versions of the questionnaired content
tes for conducting the writing sessions.
their child’s CF and identification of desired changes in the impact of the
phor.
situation or cognition and describing specifically the focus of their fear
lings.
houghts via writing a letter to a friend in a similar situation and thus to
ective of the situation and to think about it in a more functional way.
going into details regarding strategies for their friend to gain a more
he situation.
o deal with the most threatening situation, if it actually occurs.
tment-related tasks within the family and if desired planning reallocation.
of reallocation of treatment-related tasks and if not successful identification of
deal with these barriers in the future.
life and caring for oneself. Identification of own needs via using a diary for
ning enjoyable activities.
erapy contents and aims at preventing relapses via a letter to oneself.
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adapted for the current study population based on inter-
views with clinical experts in family-oriented psychosocial
care. The FoP questionnaires are judged as reliable and
valid measures for the use in research and clinical care
[10,28]. All items of the FoP-Q-C are answered on a five-
point rating scale (1 to 5) and summed up to a total score
(range 16–80). Psychometric properties in the sample of
50 caregivers being interested in WEP-CARE revealed
good psychometric properties [29]. Internal consistency in
the current study sample was good (α = .88). Moderate
positive correlations with anxiety (r = .51; p < .01) and de-
pression (r = .57; p < .01) were found, as well negative
moderate correlations to quality of life (r = −.54; p < .01).Parental quality of life
The Ulm Quality of Life Inventory for Parents of chron-
ically ill children [30] is a 29-item self-report question-
naire measuring parental quality of life (PQoL) and was
specifically developed for parents of children with chronic
conditions. Parents indicate their well-being and function-
ing for each item on a five-point rating scale (0 to 4) with
regard to the past seven days. This instrument covers
the domains physical/daily functioning, satisfaction with
family, emotional stability, self-development, well-being,
as well as a total PQoL score. Psychometric properties are
good [30]. Cronbach’s alpha in the current study ranged
between .74 and .88 for the subscales (except subscale
wellbeing α = .47) and .87 for the total score. All raw
scores were linearly transformed to 0 – 100 scales. Higher
scores indicate higher PQoL.Parental coping
The German version of the Coping Health Inventory for
Parents (CHIP) [31] was used to assess parental coping
as a collection of coping strategies being related with their
child’s chronic condition. This self-report questionnaire
comprises 45 coping behaviors. For each item parents in-
dicate the subjective effectiveness (scales between 0 and
3) of the specific strategy in the past and currently in
managing the chronic condition of the child. Total score,
as well as three subscales, describing the following coping
patterns are composed by summing up raw scores:
(I) maintaining family integration, cooperation and an op-
timistic definition of the situation (FAM), (II) maintaining
social support, self-esteem, and psychological stability
(SUP) and (III) understanding the medical situation through
communication with other parents and consultation with
medical staff (MED). Psychometric properties have
been shown to be good [31]. Cronbach’s alpha for the
three subscales ranged from .76 to .83 and was .83 for
the overall scale.Statistical considerations
Sample size
According to the a priori sample size calculation by
G-power, a sample size of N = 19 was required to detect
at least a moderate to large pre-post effect (d ≥ 0.7) on
a significance level of 5% (2-tailed) with a statistical
power of 80%. To account for potential drop-outs and
losses to follow-up we aimed to enroll a minimum of
30 participants.
Statistical analyses
All data were analyzed descriptively. Regarding the feasi-
bility of WEP-CARE, the numbers of parental caregivers
being interested and enrolled as well as the rate of par-
ticipants completing the intervention were analysed de-
scriptively. Reasons for not completing the program were
described. Furthermore, any problems to carry out the
study in accordance with the treatment manual were
described.
To examine the efficacy of the intervention for reduc-
tion of symptoms of anxiety in the completers of the inter-
vention, a paired t-test was conducted. All additional
analyses regarding the secondary outcomes were explora-
tive. For all secondary outcomes the significance level was
set at α = .05. Similarly to the analyses for the primary
outcome, paired t-tests were performed with the total
score of each measure, as well as the subscales. To exam-
ine the clinical relevance of the results Reliable Change
Indicies (RCI) [32] as well as percentages of caregivers
with improved, stable or deteriorated scores were com-
puted. The persistence of the benefits of treatment was
examined by paired t-tests comparing the scores at pre-
intervention and at the follow-up assessment. Effect
sizes (Cohen’s d) were calculated to determine the mag-
nitude of change.
Results
Study sample and feasibility
Recruitment was terminated with achievement of the sam-
ple size. Altogether, during the six months of enrolment
64 parental caregivers registered on the study website. Of
the 50 who completed the baseline assessment, 37 met
all inclusion criteria. The thirteen parental caregivers not
meeting inclusion criteria all scored below the cut-off (<8)
of the HADS anxiety subscale. Of the remaining 37
parents, three parents did not send their informed consent
statement, and three did not start with the intervention
after they were contacted by their therapist. Reasons for
not providing an informed consent or not starting the
intervention, although an informed consent had been pro-
vided, are unknown.
Of the 31 parental caregivers starting with the inter-
vention, four did not complete the program. Reasons for
not completing the intervention were: having problems
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health crisis of the child with CF (n = 1), and private
issues not related to the child’s disease (n = 2). 27 of the par-
ticipants (87.1%) were classified as completers of the inter-
vention. Furthermore, two parents were lost to post-Figure 1 WEP-CARE – CONSORT flow chart of the pilot study.assessment and another two had to be excluded from the
completer analyses, because they had started psychotherapy
or psychopharmacological treatment during the interven-
tion. All details of the progress of the participants through
the study are summarized in Figure 1.
Table 3 Characteristics of the children with CF (n = 26)
Children with CF (n = 26)
Age 5.87 years (SD = 4.8;
0–16 years)
Gender Male 14 (53.8%)
Female 12 (46.2%)
FEV1% Unknown 16 (61.6%)
<40% 0 (0%)
40-70% 1 (3.8%)
>70% 9 (34.6%)
CF related diabetes 0 (0%)
Chronic colonization with germs 5 (19.3%)
Liver problems 2 (7.6%)
Being on a waiting list for a
transplant
0 (0%)
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range 25 – 48 years), who completed the intervention
and were included in the post analyses, two were fathers
(8.7%). Most participants (n = 20; 87%) were living to-
gether with their spouse or partner and (n = 15; 65.2%)
reported to have graduated from high school. German
was the native language of all participants. Further sample
characteristics are presented in Table 2. Three of the par-
ticipants had two children with CF (11.5%), all other one.
Most of the children with CF were six years or younger
(n = 18; 69.3%). More detailed information about the
children with CF can be found in Table 3.
The intervention was performed throughout the pilot
study in accordance to the treatment manual. The par-
ticipants needed on average about three and a half
months (M =114; SD = 37.4 days; range 68–222 days) from
starting with the first writing assignment to completion of
the intervention. About 75% of the participants completed
the program within 3.2 months, but there were six persons
who needed more time. The reason was postponing writing
assignments because of unplanned disease-related tasks.Efficacy
All results for primary and secondary outcomes can be
found in Table 4.Primary endpoint
Before starting the intervention, the 23 parents scored
on average at 11.4 (SD = 2.60) points on the anxiety
subscale of the HADS. Symptoms of anxiety at post-
treatment were significantly less (t = 8.51; p < .001) com-
pared to pre-treatment. At post-treatment mean anxiety
scores (M =6.70; SD =2.60) were below the cut-off for ele-
vated symptoms of anxiety. The effect size was d = 2.06.Table 2 Characteristics of the study sample (n = 23)
Parental caregivers (n = 23)
Age 37.0 years (SD = 6.2;
25–48 years)
Gender Male 2 (8.7%)
Female 21 (91.3%)
Living situation Living together with
spouse/partner
20 (87.0%)
Single parents 3 (13.0%)
Level of education Secondary school 7 (30.4%)
University entrance
qualification
4 (17.4%)
University degree 11 (47.8%)
Other 1 (4.3%)
Employment status Employed 19 (82.2%)
Unemployed 4 (17.8%)Secondary endpoints
Comparisons between pre- and post-treatment resulted
in significantly lower fear of disease progression (t = 6.36;
p < .001) and symptoms of depression (t = 2.48; p = .02).
The effect size for fear of progression was d = 1.11 and for
depression d = .72. After the program caregivers reported
significantly higher PQoL on the total score (t = −2.78;
p = .01), as well within the domains ‘emotional stability’
(t = −8.16; p < .001), ‘self-development’ (t = −2.46; p = .02),
and ‘well-being’(t = −2.93; p = .01). Effect sizes ranged be-
tween d = .62 and 1.49. The scores on the sub-scale ‘social
support, self-esteem, and psychological stability’ were sig-
nificantly higher after the program (t = −2.13; p = .04). The
effect size was d = .51. No further effects for coping could
be found.
Clinical relevance of treatment effects
Details are shown in Table 5. A meaningful change regard-
ing individual clinically significant reduction of symptoms
of anxiety could be demonstrated for about 78% of the
parents. Further, for about half of the parents a clinically
relevant reduction of fear of disease progression, as well
as for symptoms of depression was found. Nine parents
(39%) showed clinically relevant improvements of their
overall quality of life and most of them showed no rele-
vant changes in their coping.
Follow-up
The pre-follow-up comparison (n = 20) for anxiety revealed
significant differences between baseline (M = 11.0; SD =
2.38) and three months after completion of the program
(M =7.0; SD = 3.40; t = 6.05, p < .001), resulting in an effect
size of d = 1.36.
Furthermore, paired t-tests revealed significant differences
between pre-intervention assessment and three months
follow-up for the following secondary outcomes: less fear of
Table 4 Results of the secondary endpoints of pre-post (n = 23) and 3-month follow-up (n = 20) comparisons
Pre-post comparison (n = 23) Pre-follow-up comparison (n = 20)
Outcome M (SD)
baseline
M (SD)
post
t (df) p d M (SD)
baseline
M (SD)
follow-up
t (df) p d
Symptoms of anxiety1 11.40 (2.6) 6.70 (2.6) 8.51 (22) <.001 2.06 11.00 (2.38) 7.00 (3.40) 6.05 (19) <.001 1.36
Fear of disease progression2 53.96 (11.50) 42.22 (9.60) 6.36 (22) <.001 1.11 52.70 (11.66) 40.90 (10.96) 6.10 (19) <.001 1.04
Depression2 16.96 (6.54) 12.09 (7.04) 2.48 (22) .02 .72 16.60 (6.44) 11.65 (8.41) 2.34 (19) .03 .66
Quality of life2 − Total score 49.73 (11.24) 57.88 (10.17) −2.78 (22) .01 .76 49.15 (11.33) 58.52 (14.46) −2.57 (19) .02 .72
Physical and daily functioning 53.55 (18.3) 58.98 (17.45) −1.13 (22) .27 .30 52.48 (17.39) 62.29 (20.01) −2.37 (19) .03 .52
Satisfaction with family 57.29 (19.07) 59.11 (18.12) -.51 (22) .62 .10 54.84 (18.51) 60.47(14.91) −1.26 (19) .22 .33
Emotional stability 43.21 (17.01) 64.67 (11.24) −8.16 (22) <.001 1.49 45.00 (16.76) 61.25 (19.30) −3.99 (19) .01 .90
Self-development 26.36 (17.27) 36.96 (16.85) −2.46 (22) .02 .62 26.88 (18.49) 36.56 (20.71) −1.56 (19) .14 .49
Well-being 57.34 (14.18) 68.21 (12.05) −2.93 (22) .01 .83 57.50 (13.39) 68.13 (17.07) −2.29 (19) .03 .69
Parental coping2 – Total score 69.13 (21.22) 76.21 (16.78) −1.79 (22) .09 .37 70.15 (22.59) 70.10 (22.15) .01 (19) .63 .00
FAM 32.39 (10.01) 34.95 (9.00) −1.27 (22) .22 .27 32.40 (10.67) 33.25 (9.41) -.49 (19) .85 .08
SUP 24.91 (10.37) 29.34 (6.48) −2.13 (22) .04 .51 26.05 (10.53) 25.50 (9.91) .19 (19) .70 .08
MED 11.82 (5.13) 11.91 (5.59) -.09 (22) .93 .02 11.70 (5.07) 11.35 (5.74) .39 (19) .99 .06
Annotation: 1primary outcome; 2secondary outcome; effect size d: 0.2 small, 0.5 medium, and > 0.8 large effect; FAM: Maintaining family integration, cooperation
and an optimistic definition of the situation, SUP: Maintaining social support, self-esteem, and psychological stability and III. Understanding the medical situation
through communication with other parents and consultation with medical staff.
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pression (t = 2.34; p= .03) and increased overall PQoL (total
score t =−2.57; p= .02), as well in the domains ‘emotional
stability’ (t =−3.99; p = .01), ‘well-being’ (t=−2.29; p = .03)
and ‘physical and daily functioning’ (t =−2.37; p= .03). No
significant effects could be demonstrated for parental coping
at the three-month follow-up.Conclusions
The current study aimed to evaluate a newly developed
web-based cognitive-behavioral writing therapy for dis-
tressed caregivers of children and adolescents with CF.
Altogether, the results confirm that web-based writing
therapy is feasible for parents of children and adolescents
with CF and efficacious to reduce distress and improve
quality of life.Feasibility
The aimed recruitment rate of a minimum of 30 parents
starting the intervention was achieved within a recruit-
ment period of six months. The number of parents, whoTable 5 Clinical relevance of treatment effects
RCI Reduction
Symptoms of anxiety ±3.03 18 (78.3%)
Fear of disease progression ±11.04 11 (47.8%)
Symptoms of depression ±7.69 10 (43.5%)
RCI Improved
Parental quality of life ±11.23 9 (39.1%)
Parental coping ±24.52 4 (17.4%)did not complete the program, was comparable to drop-
out rates of face-to-face psychotherapy and equal to rates
of completers reported for other web-based psychothera-
peutic interventions [33]. Reasons for not completing var-
ied and only one participant reported problems with the
setting and the structure of the program. The time needed
by the caregivers to pass through the whole program was
of high range. The different duration for completion might
be caused by intermediating time consuming demands
due to the child’s illness as well as by the high workload
and daily treatment routine in general [34]. Nevertheless,
the treatment could be conducted in accordance to the
treatment manual. Overall, our findings indicate that the
program was feasible for the participants.Efficacy – symptoms of anxiety
Significant large and clinically relevant effects could be
demonstrated on symptoms of anxiety at the end of
intervention, as well as at three-month-follow-up. On
average the caregivers’ symptoms of anxiety decreased
4.7 points on the anxiety subscale of the HADS from ann (%) Steady n (%) Increased n (%)
4 (17.4%) 1 (4.3%)
12 (52.2%) 0
11 (47.8%) 2 (8.7%)
n (%) Steady n (%) Deteriorated n (%)
11 (47.8%) 3 (13.1%)
18 (78.3%) 1 (4.3%)
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vious studies on web-based CBT for anxiety [17,35,36] or
PTSD [37].
Efficacy -fear of disease progression, depression, quality
of life, and coping
The results show that the caregivers’ fear of disease pro-
gression and symptoms of depression decreased, and par-
ental quality of life increased between pre-intervention
and post-intervention as well as between pre-intervention
and 3-month follow-up. The significant reduction of both
symptom scores indicates that participants as expected
learned to cope with perceived fears and threats related to
the illness of their child. Increase of parental quality of life
in the domains ‘emotional stability’ and ‘self-development’
is consistent with the three main treatment components
of the intervention and with the results of a systematic
review on the application, clinical efficacy, and cost-
effectiveness of internet-based cognitive behavioural ther-
apy, demonstrating large effect sizes for internet-based
treatments of depression, anxiety disorders, and health-
related anxiety [16]. Regarding parental coping, just a
trend for increase in effectiveness in coping strategies
was found for the subscale ‘maintaining social support’ at
post-treatment. Potential explanations are that the CHIP
questionnaire [31] assesses general coping patterns in
various situations rather than unique coping strategies and
that there was just one treatment component explicitly
addressing one of the three coping patterns assessed with
the CHIP, namely ‘sharing responsibility for treatment’.
Strengths and limitations
To our knowledge this is the first study evaluating a
web-based psychological intervention for caregivers of a
child with CF. However, some limitations should be men-
tioned. Due to the pilot character of this study a control
group was lacking. We are not able to draw a conclusion
whether the reported effects are specifically due to the
participation on this intervention program. We did not in-
vestigate superiority of WEP-CARE to usual care, to the
spontaneous course of psychological symptoms or to other
active comparators.
The findings should be cautiously generalized to larger
populations of caregivers due to the fact that mainly
well-educated mothers were reached for participation.
The requirement of written self-reflection might be asso-
ciated to the level of education and literacy and there-
fore could be a barrier for participation for persons with
a lower education. Gender diversity is often a problem
in psychotherapy research, also in other studies on web-
based interventions [37,38]. Moreover, as the lack of fi-
nancial resources is an important risk factor for poorer
health outcomes in pediatric respiratory diseases [39], it
should be mentioned that the requirement of internetaccess could be an additional barrier for those families
with low income. Limitations of self-report measures of
psychological symptoms should be acknowledged.
Implications for further research
Due to the preliminary results of our pilot study, WEP-
CARE can be considered a promising approach to sup-
port parental caregivers of children and adolescents with
CF. The findings can be taken as base for further efficacy
research and dissemination of the intervention. Evidence
for the specific efficacy and effectiveness can be aimed
when conducting a randomized-controlled trial comparing
to other psychological interventions, to usual care, or to
no intervention.
As previously mentioned, distress and impairments of
quality of life in caregivers of children with other pediatric
chronic conditions is a well-known issue [6,40], which
needs to be addressed. Transferability of the WEP-CARE
for other rare and chronic diseases indicating the need to
provide support to caregivers can be considered.
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